{
  "abstract": "Hypoglycaemia, or low blood sugar (BS), is a potentially serious side effect of diabetes treatment that adversely impacts brain function. 1 Newer classes of diabetes medications such as glucagon-like peptide-1 (GLP-1) agonists, sodium-glucose co-transporter-2 (SGLT-2) inhibitors, dipeptidyl peptidase-4 inhibitors and thiazolidinediones (TZDs) have minimal risk of hypoglycaemia when used on their own.2 Moreover, newer BS management approaches using continuous glucose monitors (CGMs) provide a tool to recognise impending low BS levels as a means to prevent clinical hypoglycaemia.3 Little is known about how these developments affect hypoglycaemic emergencies. We describe temporal trends in emergency medical services (EMS) incidents involving hypoglycaemia.",
  "authors": [
    {
      "affiliations": [
        "Public Health Seattle and King County Emergency Medical Services Division, Seattle, Washington, USA"
      ],
      "name": "Camilla C Osborne"
    },
    {
      "affiliations": [
        "Public Health Seattle and King County Emergency Medical Services Division, Seattle, Washington, USA",
        "Department of Medicine, University of Washington, Seattle, Washington, USA"
      ],
      "name": "Thomas D Rea"
    },
    {
      "affiliations": [
        "Emergency Medicine, University of Washington, Seattle, Washington, USA"
      ],
      "name": "Andrew M McCoy"
    },
    {
      "affiliations": [
        "School of Pharmacy, University of Washington, Seattle, Washington, USA"
      ],
      "name": "Mary S Kelly"
    },
    {
      "affiliations": [
        "Emergency Medicine, University of Washington, Seattle, Washington, USA"
      ],
      "name": "Michael R Sayre"
    },
    {
      "affiliations": [
        "Emergency Medicine, University of Washington, Seattle, Washington, USA"
      ],
      "name": "David L Murphy"
    }
  ],
  "title": "Declining incidence and severity of hypoglycaemia in prehospital care",
  "uid": "35cde062-f4e1-57f4-8127-4ced18722d2d"
}